Software services firm HCl Technologies has acquired C3i Solutions for USD 60 million, a move aimed at accelerating the Indian IT firm’s growth in life sciences and consumer services. C3i Solutions is a wholly owned, independently operated subsidiary of Merck & Co, (known as MSD outside the US and Canada). It provides multi-channel customer engagement services for life sciences and consumer packaged goods (CPG) industries. C3i’s expertise in the clinical, pharmacovigilance, and pharma sales support domains and the strong partnership will enable HCl’s life sciences customers to become more patient-centric and offer services to IT and business stakeholders.